Meditherapy announced that it has received KRW 26,000,000,000 in a round of funding on April 9, 2024. The transaction included participation from new investors Company K Partners Limited, Korea Investment Partners Co. Ltd. and DSC Investment Inc.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,040 KRW | +1.15% | +1.88% | +5.55% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
7,040 KRW | +1.15% | +1.88% | 8.12Cr | ||
3,810 KRW | +1.20% | +1.74% | 7.46Cr | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.55% | 8.12Cr | |
+14.52% | 305.28Cr | |
+31.41% | 206.11Cr | |
+8.00% | 150.9Cr | |
-11.54% | 120.12Cr | |
+14.37% | 76Cr | |
+9.28% | 67Cr | |
+33.12% | 57Cr | |
-4.17% | 50Cr | |
+25.78% | 47Cr |
- Stock Market
- Equities
- A307930 Stock
- News Company K Partners Limited
- Meditherapy announced that it has received KRW 26 billion in funding from Company K Partners Limited, Korea Investment Partners Co. Ltd., DSC Investment Inc.